| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Département d'Anesthésie Réanimation, Hôpital Bicêtre, Bicêtre and
Département d'Anesthésie Réanimation, Hôpital Raymond Poincaré, Garches, France.
Address correspondence to: Dr. Dominique Fletcher, Département d'Anesthésie Réanimation, Hôpital Raymond Poincaré, 104 boulevard Raymond, Poincaré 92380, Garches, France. Phone: 33-1-47107622; Fax: 33-1-47107623; E-mail: dar.garches{at}rpc.ap-hop-paris.fr
| Abstract |
|---|
|
|
|---|
Methods: Forty patients received general anesthesia for total hip arthroplasty (THA) and were divided into two groups of 20. In the Peroperative group (Perop group;) morphine was titrated at the end of surgery (3 mg iv every 5 or 10 min) in spontaneously breathing intubated patients, until the respiratory rate (RR) decreased. No morphine was administered to Postop group. In the Post Anesthesia Care Unit (PACU) patients in Perop and Postop groups received morphine until adequate pain relief VAS
30 mm. Patients used patient-controlled analgesia (PCA) for the next 24 hr. In the PACU, the delay for analgesia, doses of morphine used and incidence of side effects were recorded.
Results: In the Perop group, patients received 10.3 ± 1.3 mg (2-20 mg) as peroperative titration and had achieved adequate analgesia more rapidly than in the Postop group (42 ± 7 min vs 76 ± 7 min ); P = 0.0026). Analgesia in the PACU in the Postop group required larger doses of morphine (15.4 ± 1.5 mg;) than in the Perop group (7.3 ± 1.3 mg; P = 0.0004). The respiratory rate decrease during peroperative morphine titration was correlated to the morphine dose needed in the PACU (P = 0.035). Respiratory depression in the PACU was more common in the Postop group than in the Perop group (five patients vs no patient P = 0.017).
Conclusion: This study demonstrated that the peroperative administration of morphine can facilitate immediate postoperative pain management.
| Introduction |
|---|
|
|
|---|
| Material and methods |
|---|
|
|
|---|
The patients were excluded in the case of prescription of other analgesics drugs than the morphine in the operating room or the PACU. They were randomly allocated to two groups using a random number table: Peroperative morphine (Perop group) with peroperative titration of morphine and Postoperative morphine group (Postop group) with no peroperative titration of morphine.
Anesthesia and peroperative administration of morphine
All patients received 2 mgkg1 hydroxyzine 120 min before surgery. General anesthesia was induced with 3-5 mgkg1 thiopental, 0.1 mgkg1 pancuronium or 1-1.5 mgkg1 succinylcholine and 1.5 µgkg1 fentanyl. The trachea was intubated and anesthesia was maintained with O2/N2O and isoflurane. Reinjection of fentanyl was allowed at the discretion of the anesthesiologist responsible for the case, with the last injection of opioid 30 min before the presumed end of surgery (i.e. at the end of skin closure).
The peroperative morphine group (Perop group) received peroperative morphine titration administered while muscle and skin closure was performed with patients emerging from anesthesia and spontaneously breathing via an orotracheal tube. After discontinuation of isoflurane and neuromuscular reversal when necessary as determined by train-of-four stimulation, boluses of morphine were administered according to two protocols in alternate patients in the Perop group: 3 mg every five minutes and 3 mg every 10 min. The titration was continued until the respiratory rate (RR) decreased with a lowest RR of 12 breathsmin1 (bpm). During this titration the PETCO2, tidal volume and the isofluraneET concentration were monitored.
Postoperative pain management and evaluation
Personnel involved in patient management and data collection in the PACU were unaware of the group to which the patient had been assigned. In case of emergency the anesthesiologist responsible for the patient in the PACU had access to the patient allocation. After arrival in the Post Anesthesia Care Unit (PACU), when the patients were completely awake (i.e. sedation score
2) and capable of using the visual analog scale (VAS), pain was controlled by titration of intravenous morphine administered by a nurse. A 10-cm VAS (with endpoints labeled "no pain" and "worst possible pain") was used to assess pain intensity at rest. The sedation was monitored using the following scale: 0 - patient fully alert; 1 - patient with intermittent sedation; 2 - patient sedated but responsive to verbal stimuli; 3 - patient unresponsive to verbal stimuli. All patients received 3-5 lmin1 supplemental oxygen in the PACU. Morphine titration in the PACU consisted of repeated boluses of 3 mg morphine every 10 min (2 mg every 10 min > 65 yr) until the pain score was reported as
30 mm on a visual analog scale by the patient. Side effects (nausea, vomiting, pruritus, urinary retention) were recorded if present. Respiratory depression was defined in the PACU as the combination of sedation (sedation score
2) and hypoxemia with a SpO2 < 95 or the combination of a sedation score
2 and a respiratory rate
10 bpm.
The titration was stopped in case of a sedation score = 3 or respiratory depression (i.e. sedation score
2 and RR
10 bpm). The titration was also interrupted when the VAS pain score remained
50 mm for > 60 min after the start of morphine administration. In case of inadequate analgesia, the anesthesiologist responsible for the patient could administer a non opioid analgesic drug as propacetamol (Pro-DafalganTM a prodrug of acetaminophen UPSA laboratory Rueil Malmaison France) or ketoprofen (ProfenidTM Specia Laboratory Rueil Malmaison France).
Delay in adequate pain control was defined as the interval between the time of arrival in the PACU and the first visual analog pain score
30. In case of failure of postoperative titration due to sedation, respiratory depression or persistent high pain score > 60 min, duration of morphine titration was considered as the delay for pain control.
Subsequently, patients were given access to a patient-controlled analgesia (PCA) pump (PCA II Bard). The pump was set to deliver a 1 mg bolus of morphine iv, a lock-out time of eight minutes and a maximum cumulative dose of 24 mg every four hours without a continuous infusion. This regimen of PCA was continued for 24 hr on the surgical ward, during which time other analgesics were administered when necessary.
The difficulty of pain control was evaluated at PACU discharge with a verbal scale by the nurses (very easy; easy; rather difficult; difficult; very difficult). The patients also evaluated pain control (inadequate; reasonable; good; perfect) and side effects (none, present not disturbing, disturbing, very disturbing). The Aldrete score criteria were used to define when the patient may be discharged from the PACU.
Data analysis
The Mann Whitney U test was used to compare continuous variables. Regression analysis was used to evaluate the relation between peroperative titration and the quality of postoperative analgesia. Chi square test was used to compare frequency of side effects and sex distribution. A value of P < 0.05 was considered significant. Data are expressed as mean ± SEM (range).
| Results |
|---|
|
|
|---|
|
|
|
|
50 mm after one hour of morphine). In these patients, VAS pain score was still high (50-70 mm) 60 min after the start of morphine titration using 21 mg morphine. Thus, there were five failures of titration in the Postop group (three respiratory depression, two persistent high pain score) compared with two failures in the Perop group (two persistent high pain score) (P : NS). The management of pain was considered as very easy to easy for 15 patients in the Perop group vs nine patients in the Postop group (P : NS). Patient evaluation of pain control showed good to excellent pain control in 13 patients in the Perop group vs eight patients in the Postop group (P : NS) and side effects for eight patients in the Perop group vs ten patients in the Postop group (P : NS).
| Discussion |
|---|
|
|
|---|
This study is the first to suggest that peroperative morphine titration can facilitate postoperative pain management both in the quality of pain control and reduction of respiratory depression. Peroperative administration of a single morphine bolus as part of clinical practice has been suggested by some studies describing this technique,14 but the realization of peroperative morphine titration using repeated morphine boluses is rarely described,6 and has not been validated. The doses of peroperative morphine bolus previously evaluated varied between 0.15 and 0.25 mgkg1 20 to 30 min before the end of surgery.14 In our study, the mean total dose of morphine titrated in anesthetized patients was close to 0.15 mgkg1.
Previous studies have suggested that peroperative administration of a single bolus of morphine (0.1 mgkg1) did not modify the awakening concentration of isoflurane or sevoflurane.7,8 Similarly, in this study, extubation of the trachea was possible in all patients in the Perop group although no precise criteria for extubation were used. However, the range of the duration of peroperative titration (10-55 min) suggests that this titration may have delayed extubation in some patient. Our data show that the delay before adequate analgesia was achieved in the PACU can be reduced by 45% with peroperative titration. Peroperative morphine titration does not preclude morphine administration to complete analgesia in the PACU. The more intense analgesia obtained in the Perop group cannot be totally explained by an increase in total amount of morphine given which was not different between the groups. This more rapid analgesia in the PACU may be due to a shift in the timing to analgesia in the Perop group. In addition to the more rapid adequate analgesia, the patients of the Perop group had no incidence of respiratory depression as compared with five cases in the Postop group. The higher morphine dose used in the PACU in the Postop group may explain this higher incidence of respiratory depression. These cases of respiratory depression in the Postop group did not require naloxone antagonism or mechanical ventilation. This is probably related to the criteria used in our study to define respiratory depression which allowed detection of early signs of opioid overdosage. Other authors have observed that a peroperative bolus of 0.25 mgkg1 morphine enhances analgesia after remifentanil-based anesthesia but is responsible for severe delayed postoperative respiratory depression requiring antagonization or ventilation.2 Our peroperative titration may have limited the incidence of respiratory depression by adapting the dose of opioid to the interindividual variability.5
What is the validity of the respiratory rate (RR) as a criterion of adequate peroperative morphine titration? The target of a respiratory rate of 12 bpm initially chosen does not seem easy to reach. A slight majority of patient reached that target. These patients had good pain control according to the important reduction of the delay of analgesia and morphine need in the PACU. The RR at the beginning of peroperative titration varies among patients. The RR decrease during peroperative titration seems correlated to the quality of postoperative analgesia as reflected by the parallel reduced amount of morphine needed in the PACU to complete analgesia although this is not confirmed by a correlation with a shorter delay for adequate analgesia. However, although the dose of peroperative titrated morphine was correlated to the degree of peroperative RR decrease, this dose of morphine was not correlated to the delay for adequate analgesia and the dose of morphine needed in the PACU. Therefore, the RR decrease during administration of peroperative titrated morphine may be helpful both for safety (i.e. no reduction of RR beyond 12 bpm) and quality of analgesia (degree of RR decrease). However this weak correlation (r2 of 0.24) means that only a partial prediction of postoperative morphine needs in the PACU by the peroperative RR decrease.
In conclusion, the peroperative administration of morphine titrated according to RR reduction in patients emerging from anesthesia can enhance the immediate postoperative analgesia, limit the incidence of respiratory depression and facilitate the management of pain in the PACU.
Accepted for publication December 22, 1999.
| References |
|---|
|
|
|---|
2 Chauvin M, Lejus C, Scherpereel P, Cheli-Muller L, Hédouin M. Control of immediate postoperative pain in patients who received remifentanil during balanced anaesthesia for severely painful surgery. Br J Anaesth 1998; 80(Suppl1): A613.
3 Sneyd JR. Morphine before the termination of remifentanil provides effective transition to routine analgesia after major surgery: a comparison with current practice. Br J Anaesth 1998; 80(Suppl1): A614.
4
Coetzee JF, van Loggerenberg H. Tramadol or morphine administered during operation: a study of immediate postoperative effects after abdominal hysterectomy. Br J Anaesth 1998; 81: 73741.
5
Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. Fentanyl blood concentration - analgesic response relationship in the treatment of postoperative pain. Anesth Analg 1988; 67: 32937.
6 Christopherson R, Beattie C, Frank SM, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Anesthesiology 1993; 79: 42234.[Medline]
7
Gross JB, Alexander CM. Awakening concentrations of isoflurane are not affected by analgesic doses of morphine. Anesth Analg 1988; 67: 2730.
8
Katoh T, Suguro Y, Kimura T, Ikeda K. Morphine does not affect the awakening concentration of sevoflurane. Can J Anaesth 1993; 40: 8258.
This article has been cited by other articles:
![]() |
F. Aubrun, J. Amour, D. Rosenthal, P. Coriat, and B. Riou Effects of a loading dose of morphine before i.v. morphine titration for postoperative pain relief: a randomized, double-blind, placebo-control study Br. J. Anaesth., January 1, 2007; 98(1): 124 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dahmani, H. Dupont, J. Mantz, J. M. Desmonts, and H. Keita Predictive factors of early morphine requirements in the post-anaesthesia care unit (PACU) Br. J. Anaesth., September 1, 2001; 87(3): 385 - 389. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |